Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
9.72
-0.26 (-2.61%)
At close: May 28, 2025, 4:00 PM
9.42
-0.30 (-3.09%)
After-hours: May 28, 2025, 4:10 PM EDT
Greenwich LifeSciences Market Cap
Greenwich LifeSciences has a market cap or net worth of $129.94 million as of May 28, 2025. Its market cap has decreased by -26.62% in one year.
Market Cap
129.94M
Enterprise Value
127.19M
1-Year Change
-26.62%
Ranking
Category
Stock Price
$9.72
Market Cap Chart
Since the IPO on September 25, 2020, Greenwich LifeSciences's market cap has increased from $68.69M to $129.94M, an increase of 89.17%. That is a compound annual growth rate of 14.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 28, 2025 | 129.94M | -11.97% |
| Dec 31, 2024 | 147.61M | 9.21% |
| Dec 29, 2023 | 135.16M | -30.79% |
| Dec 30, 2022 | 195.29M | -38.84% |
| Dec 31, 2021 | 319.29M | -31.08% |
| Dec 31, 2020 | 463.30M | 574.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 640.72B |
| Johnson & Johnson | 367.98B |
| AbbVie | 323.71B |
| Novo Nordisk | 311.77B |
| UnitedHealth Group | 268.12B |
| Abbott Laboratories | 228.44B |
| Novartis AG | 224.07B |
| AstraZeneca | 219.48B |